VERTEX PHARMACEUTICALS INC / MA Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) of -$10.02 million for the 108-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveAccrualAdjustment · last filed 2013-03-01
- VERTEX PHARMACEUTICALS INC / MA restructuring reserve, accrual adjustment (deprecated 2016-01-31) for fiscal 2012 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring reserve, accrual adjustment (deprecated 2016-01-31) for fiscal 2011 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring reserve, accrual adjustment (deprecated 2016-01-31) for fiscal 2010 was $0.00.
| Period end | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 12 month | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 84 month | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 96 month | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) 108 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-01 | -$10.02M 10-K · filed 2013-03-01 | ||
| 2011-12-31 | $0.00 10-K · filed 2013-03-01 | -$10.02M 10-K · filed 2012-02-22 | ||
| 2010-12-31 | $0.00 10-K · filed 2013-03-01 | -$10.02M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |